Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
NeuroNetworks Fund
AddedFeb 15, 2024
UpdatedJun 28, 2026
NeuroNetworks Fund

NeuroNetworks Fund

Operating

NeuroNetworks Fund: A venture fund investing in innovative neurodisorder treatments, bridging the funding gap and promoting self-sustainability.

Location
New York City, NY, US
Firm
Compare
Portfolio
Employees
Website

NeuroNetworks Fund focuses on investing in innovative treatments for neurodisorders, specifically targeting autism, epilepsy, and schizophrenia. The fund aims to bridge the gap between government funding and private capital in the neurodisease sector, accelerating the development of promising products that address unmet medical needs.

The fund's portfolio includes Stemina Biomarker Discovery, which has raised $3.1 million. NeuroNetworks Fund employs a unique model that combines philanthropic fundraising with venture capital investment, allowing them to support entrepreneurial companies developing new drugs and treatments. This approach helps promote self-sustainability in the neurodisorder treatment space.

NeuroNetworks Fund - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments2
Current Portfolio Count2
Total Portfolio Exits0

Top Investment Stages

Series A1 (50.0%)
Series Unknown1 (50.0%)

Stage Mix

Series A 50%Series Unknown 50%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Eysz logo

Eysz

Stemina Biomarker Discovery logo

Stemina Biomarker Discovery

NeuroNetworks Fund - Similar Investment Firms

NeuroVentures Capital logo

NeuroVentures Capital

neuroventures.com

Brain Trust Accelerator Fund logo

Brain Trust Accelerator Fund

braintrustvc.com

NeuroLaunch logo

NeuroLaunch

neurolaunch.com

Pathway to Cures logo

Pathway to Cures

pathwaytocures.org

Noetic Fund logo

Noetic Fund

noeticfund.com

Brain Tumor Investment Fund logo

Brain Tumor Investment Fund

Neu Venture Capital logo

Neu Venture Capital

neuvc.com

Empath Ventures logo

Empath Ventures

empath.vc

Founders Network Fund logo

Founders Network Fund

Acorn Bioventures logo

Acorn Bioventures

Nueterra Capital logo

Nueterra Capital

nueterra.com

Dementia Discovery Fund logo

Dementia Discovery Fund

ddf.vc

Bio/Med Investor Network logo

Bio/Med Investor Network

Nucleus Capital logo

Nucleus Capital

Narrative Fund logo

Narrative Fund

NeuroNetworks Fund - Classification

NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 2 more industry codes
NAICS
  • 520000Finance and Insurance
SIC
  • 6000Depository Institutions